Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through ...

A new research paper was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “Computed tomography-based ...

However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose UDCA in patients with primary sclerosing cholangitis (PSC) may be harmful; adverse events ...

Discover a study in which liver dysmorphy was observed in 95% of patients with a high ANALI score, and it was significantly ...

Primary sclerosing cholangitis (PSC) is a chronic autoimmune disease with inflammation and stricture formation in the bile ducts inside the liver and/or in the extrahepatic bile duct which drains into ...

A Wisconsin State Patrol lieutenant who has been living with chronic liver disease for more than a decade underwent a liver ...

Primary sclerosing cholangitis can lead to cirrhosis and failure of the liver. The causes of this condition are not clear, but it is often linked to ulcerative colitis and inflammatory bowel disease.

This study reveals the potential for prognostic features in predicting hepatic decompensation in patients with PSC."BUFFALO, NY – December 9, 2024 – ...

(Nasdaq: MIRM) today announced that on December 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted ...

other biliary diseases including primary sclerosing cholangitis, alcohol consumption, infiltrative or granulomatous liver diseases such as hepatic sarcoidosis, and bone diseases. Biopsies remain ...